(3r)-((2,3-dihydro-5-methyl-3-((4-morpholinyl)methyl)pyrrolo-(1,2,3-de)-1,4-benzoxazin-6-yl)(1-naphthalenyl))methanone and cp-55,940

(3r)-((2,3-dihydro-5-methyl-3-((4-morpholinyl)methyl)pyrrolo-(1,2,3-de)-1,4-benzoxazin-6-yl)(1-naphthalenyl))methanone has been researched along with cp-55,940 in 39 studies

Research

Studies (39)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	6 (15.38)	18.2507
2000's	11 (28.21)	29.6817
2010's	19 (48.72)	24.3611
2020's	3 (7.69)	2.80

Authors

Authors	Studies
Abu-Shaar, M; Munro, S; Thomas, KL	1
Blond, O; Briley, EM; Felder, CC; Joyce, KE; Lai, Y; Ma, AL; Mackie, K; Mansouri, J; Mitchell, RL	1
Bonnin-Cabanne, O; Calandra, B; Caput, D; Ferrara, P; Le Fur, G; Oustric, D; Pessègue, B; Rinaldi-Carmona, M; Shire, D	1
Abood, ME; Compton, DR; Martin, BR; Showalter, VM	1
Fan, P; Goutopoulos, A; Khanolkar, AD; Lin, S; Makriyannis, A; Papahadjis, D; Qin, C	1
Govaerts, SJ; Hermans, E; Kanyonyo, M; Lambert, DM; Poupaert, JH	1
Bianchi, A; Cruciani, G; Fichera, M; Musumarra, G	1
Fernández-Ruiz, J; González, S; Lastres-Becker, I; López-Rodríguez, ML; Ortega-Gutiérrez, S; Ramos, JA; Viso, A	1
Fowler, CJ; Lambert, DM	1
Buonerba, M; Cascio, MG; Cavallo, P; De Martino, G; Di Marzo, V; Saturnino, C; Urbani, P	1
Chavatte, P; Depreux, P; Farce, A; Goossens, JF; Hénichart, JP; Lambert, DM; Millet, R; Muccioli, GG; Poupaert, JH; Stern, E	1
Abood, M; Fleischer, D; Hurst, D; Hyatt, S; Jones, J; Kapur, A; Lewis, D; Lynch, D; McAllister, S; Reggio, P; Roche, M; Seltzman, H; Shi, S; Umejiego, U	1
Burton, M; Christophe, B; De Ryck, M; Lambeng, N; Lebon, F; Quéré, L	1
Bevan, SJ; Brain, CT; Coote, PR; Culshaw, AJ; Davis, AJ; Dziadulewicz, EK; Edwards, LJ; Fisher, AJ; Fox, AJ; Gentry, C; Groarke, A; Hart, TW; Huber, W; James, IF; Kesingland, A; La Vecchia, L; Loong, Y; Lyothier, I; McNair, K; O'Farrell, C; Peacock, M; Portmann, R; Schopfer, U; Yaqoob, M; Zadrobilek, J	1
Bosier, B; Depreux, P; Goossens, JF; Hamtiaux, L; Hénichart, JP; Lambert, DM; Millet, R; Muccioli, GG; Poupaert, JH; Stern, E	1
Albrecht, BK; Brown, J; Buchanan, JL; Buckner, WH; Cheng, Y; DiMauro, EF; Emkey, R; Fremeau, RT; Harmange, JC; Hitchcock, SA; Hoffman, BJ; Huang, L; Huang, M; Lee, JH; Lin, FF; Martin, MW; Nguyen, HQ; Patel, VF; Tomlinson, SA; White, RD; Xia, X	1
Behrenswerth, A; Bräse, S; Hinz, S; Müller, CE; Toräng, J; Volz, N	1
Attali, A; Duursma, A; Lange, JH; Mulder, A; van Aken, HH; van der Neut, MA; van Vliet, BJ; Wals, HC; Zilaout, H	1
Andrzejak, V; Body-Malapel, M; Chavatte, P; Desreumaux, P; Djouina, M; El Bakali, J; Hamtiaux, L; Lambert, DM; Millet, R; Muccioli, GG; Pradal, D; Renault, N	1
Adam, JM; Baker, J; Cairns, J; Cottney, JE; Cowley, P; Ferguson, M; Houghton, AK; Jeremiah, F; Kiyoi, T; McPhail, P; Moir, EM; Morphy, R; Osprey, A; Tierney, J; Walker, G; Wishart, G; York, M; Yoshiizumi, K	1
Brogi, S; Corelli, F; Di Marzo, V; Ligresti, A; Mugnaini, C; Pasquini, S; Tafi, A	1
Adam, JM; Baker, J; Campbell, R; Clark, JK; Cottney, JE; Davies, K; Deehan, M; Easson, AM; Edwards, D; Epemolu, O; Evans, L; Feilden, H; Fields, R; Francis, S; Jeremiah, F; Kiyoi, T; McArthur, D; Morrison, AJ; Prosser, A; Ratcliffe, PD; Schulz, J; Wishart, G	1
Blaazer, AR; den Boon, FS; Kruse, CG; Lange, JH; Mulder, A; van der Neut, MA; Wadman, WJ; Werkman, TR	1
Aiello, F; Biotti, I; Brizzi, A; Brizzi, V; Cascio, MG; Corelli, F; Di Marzo, V; Frosini, M; Ligresti, A; Pertwee, RG	1
Adam, JM; Baker, J; Boyce, S; Campbell, R; Clark, JK; Cottney, JE; Davies, K; Deehan, M; Everett, K; Fields, R; Francis, S; Jeremiah, F; Kiyoi, T; Maidment, M; Martin, I; Morrison, A; Prosser, A; Ratcliffe, P; Schulz, J; Wishart, G	1
Andrzejak, V; Body-Malapel, M; Chavatte, P; Desreumaux, P; Djouina, M; El Bakali, J; Lambert, DM; Leleu-Chavain, N; Lemaire, L; Lemoine, A; Mansouri, R; Millet, R; Muccioli, GG; Renault, N; Rigo, B; Tourteau, A	1
Buzard, DJ; Han, S; Jones, RM; Thatte, J	1
Barth, F; Cavasotto, CN; Chen, SR; Diaz, F; Diaz, P; Knight, L; Mackie, K; McDaniel, SW; Pan, HL; Petrov, RR; Wager-Miller, J	1
Brust, P; Günther, R; Lueg, C; Schepmann, D; Wünsch, B	1
Aiello, F; Brizzi, A; Brizzi, V; Cascio, MG; Corelli, F; De Petrocellis, L; Di Marzo, V; Lamponi, S; Ligresti, A; Luongo, L; Maione, S; Marini, P; Pertwee, RG	1
Chicca, A; Curini, M; Gertsch, J; Messina, F; Pelosi, A; Petrucci, V; Rosati, O	1
Carrillo-Salinas, FJ; Fernández-Ruiz, J; Franco, R; Gómez-Cañas, M; Goya, P; Guaza, C; Hurst, DP; Jagerovic, N; Lagartera, L; Morales, P; Navarro, G; Pazos, R; Reggio, PH	1
Cooper, AG; Glass, M; Hook, S; MacDonald, C; Tyndall, JDA; Vernall, AJ	1
Abate, M; Arena, C; Bertini, S; Bifulco, M; Chicca, A; Ciaglia, E; Digiacomo, M; Gado, F; Gertsch, J; Lapillo, M; Macchia, M; Manera, C; Poli, G; Tuccinardi, T	1
Cheng, J; McCorvy, JD; Tan, L; Yan, W	1
de Vries, H; Frehland, B; Heimann, D; Heitman, LH; Lueg, C; Schepmann, D; Wünsch, B	1
Belardo, C; Cannazza, G; Citti, C; Forni, F; Gigli, G; Laganà, A; Linciano, P; Luongo, L; Maione, S; Montone, CM; Vandelli, MA	1
Aiello, F; Boccella, S; Brizzi, A; Cascio, MG; Corelli, F; De Petrocellis, L; Di Marzo, V; Frosini, M; Gado, F; Ligresti, A; Luongo, L; Maione, S; Manera, C; Marini, P; Mugnaini, C; Pertwee, RG; Pessina, F	1
Cheng, J; Duan, W; Hua, T; Li, F; Liu, ZJ; Nie, H; Sun, Y; Wang, H; Wu, M; Xu, Y; Yang, L; Zhang, T; Zhang, Z	1

Reviews

3 review(s) available for (3r)-((2,3-dihydro-5-methyl-3-((4-morpholinyl)methyl)pyrrolo-(1,2,3-de)-1,4-benzoxazin-6-yl)(1-naphthalenyl))methanone and cp-55,940

Article	Year
The endocannabinoid system: drug targets, lead compounds, and potential therapeutic applications. Journal of medicinal chemistry, 2005, Aug-11, Volume: 48, Issue:16 Topics: Amides; Amidohydrolases; Amines; Animals; Arachidonic Acids; Binding Sites; Cannabinoid Receptor Modulators; Drug Design; Endocannabinoids; Esters; Ethers; Glycerides; Humans; Ligands; Monoacylglycerol Lipases; Polyunsaturated Alkamides; Receptors, Cannabinoid	2005
Therapeutic utility of cannabinoid receptor type 2 (CB(2)) selective agonists. Journal of medicinal chemistry, 2013, Nov-14, Volume: 56, Issue:21 Topics: Animals; Drug Design; Humans; Ligands; Models, Molecular; Molecular Conformation; Receptor, Cannabinoid, CB2; Structure-Activity Relationship; Substrate Specificity	2013
Biased Ligands of G Protein-Coupled Receptors (GPCRs): Structure-Functional Selectivity Relationships (SFSRs) and Therapeutic Potential. Journal of medicinal chemistry, 2018, 11-21, Volume: 61, Issue:22 Topics: Animals; Drug Discovery; Humans; Ligands; Receptors, G-Protein-Coupled; Signal Transduction; Structure-Activity Relationship	2018

Other Studies

36 other study(ies) available for (3r)-((2,3-dihydro-5-methyl-3-((4-morpholinyl)methyl)pyrrolo-(1,2,3-de)-1,4-benzoxazin-6-yl)(1-naphthalenyl))methanone and cp-55,940

Article	Year
Molecular characterization of a peripheral receptor for cannabinoids. Nature, 1993, Sep-02, Volume: 365, Issue:6441 Topics: Amides; Amino Acid Sequence; Animals; Arachidonic Acids; Base Sequence; Benzoxazines; Brain; Cannabinoids; Cloning, Molecular; DNA; Endocannabinoids; Fatty Acids, Unsaturated; Humans; Macrophages; Molecular Sequence Data; Morpholines; Naphthalenes; Polyunsaturated Alkamides; Rats; Receptors, Cannabinoid; Receptors, Drug; RNA; Spleen; Tumor Cells, Cultured	1993
Comparison of the pharmacology and signal transduction of the human cannabinoid CB1 and CB2 receptors. Molecular pharmacology, 1995, Volume: 48, Issue:3 Topics: Adenylyl Cyclase Inhibitors; Adenylyl Cyclases; Amidohydrolases; Animals; Arachidonic Acids; Base Sequence; Binding, Competitive; Calcium; Calcium Channel Blockers; Cannabinoids; CHO Cells; Cricetinae; Endocannabinoids; Enzyme Activation; Humans; Intracellular Fluid; Ion Channels; Kinetics; Mice; Molecular Sequence Data; Phospholipases; Polyunsaturated Alkamides; Rats; Receptor, Cannabinoid, CB2; Receptors, Cannabinoid; Receptors, Drug; Signal Transduction; Transfection	1995
Molecular cloning, expression and function of the murine CB2 peripheral cannabinoid receptor. Biochimica et biophysica acta, 1996, Jun-07, Volume: 1307, Issue:2 Topics: Amino Acid Sequence; Animals; Base Sequence; Cannabinoids; Cloning, Molecular; DNA, Complementary; Humans; Mice; Molecular Sequence Data; Receptors, Cannabinoid; Receptors, Drug; Sequence Homology, Amino Acid	1996
Evaluation of binding in a transfected cell line expressing a peripheral cannabinoid receptor (CB2): identification of cannabinoid receptor subtype selective ligands. The Journal of pharmacology and experimental therapeutics, 1996, Volume: 278, Issue:3 Topics: Animals; Binding, Competitive; Brain; Cannabinoids; Cell Membrane; Cells, Cultured; CHO Cells; Cricetinae; Cyclohexanols; Guanine Nucleotides; Humans; Ligands; Rats; Receptor, Cannabinoid, CB2; Receptors, Cannabinoid; Receptors, Drug; Recombinant Proteins; Sodium; Structure-Activity Relationship; Transfection	1996
Novel analogues of arachidonylethanolamide (anandamide): affinities for the CB1 and CB2 cannabinoid receptors and metabolic stability. Journal of medicinal chemistry, 1998, Dec-31, Volume: 41, Issue:27 Topics: Amidohydrolases; Animals; Arachidonic Acids; Brain; Cannabinoids; Endocannabinoids; Guanosine 5'-O-(3-Thiotriphosphate); In Vitro Techniques; Mice; Polyunsaturated Alkamides; Radioligand Assay; Rats; Receptor, Cannabinoid, CB2; Receptors, Cannabinoid; Receptors, Drug; Serine Proteinase Inhibitors; Spleen; Structure-Activity Relationship; Tosyl Compounds	1998
3-Alkyl-(5,5'-diphenyl)imidazolidineiones as new cannabinoid receptor ligands. Bioorganic & medicinal chemistry letters, 1999, Aug-02, Volume: 9, Issue:15 Topics: Animals; Cannabinoids; CHO Cells; Cricetinae; Humans; Imidazoles; Ligands; Piperidines; Pyrazoles; Receptors, Cannabinoid; Receptors, Drug; Rimonabant; Structure-Activity Relationship; Transfection	1999
A 3D-QSAR study on the structural requirements for binding to CB(1) and CB(2) cannabinoid receptors. Journal of medicinal chemistry, 2000, Jun-15, Volume: 43, Issue:12 Topics: Arachidonic Acids; Cannabinoids; Drug Design; Endocannabinoids; Indoles; Ligands; Models, Biological; Models, Molecular; Polyunsaturated Alkamides; Receptors, Cannabinoid; Receptors, Drug; Structure-Activity Relationship	2000
Design, synthesis and biological evaluation of novel arachidonic acid derivatives as highly potent and selective endocannabinoid transporter inhibitors. Journal of medicinal chemistry, 2001, Dec-20, Volume: 44, Issue:26 Topics: Animals; Arachidonic Acids; Cannabinoid Receptor Modulators; Cannabinoids; Carrier Proteins; Cell Line; Cerebellum; Drug Design; Endocannabinoids; Furans; Humans; In Vitro Techniques; Membranes; Polyunsaturated Alkamides; Radioligand Assay; Receptors, Cannabinoid; Receptors, Drug; Spinal Cord; Structure-Activity Relationship	2001
New metabolically stable fatty acid amide ligands of cannabinoid receptors: Synthesis and receptor affinity studies. Bioorganic & medicinal chemistry letters, 2006, Jan-01, Volume: 16, Issue:1 Topics: Amides; Amidohydrolases; Arachidonic Acid; Arachidonic Acids; Cannabinoid Receptor Modulators; Cannabinoids; Cell Line; Chemistry, Pharmaceutical; Chromatography; Drug Design; Endocannabinoids; Fatty Acids; Humans; Inhibitory Concentration 50; Kinetics; Ligands; Models, Chemical; Polyunsaturated Alkamides; Protein Binding; Protein Structure, Tertiary; Receptors, Cannabinoid; Recombinant Proteins	2006
Novel 4-oxo-1,4-dihydroquinoline-3-carboxamide derivatives as new CB2 cannabinoid receptors agonists: synthesis, pharmacological properties and molecular modeling. Journal of medicinal chemistry, 2006, Jan-12, Volume: 49, Issue:1 Topics: Crystallography, X-Ray; Humans; Models, Molecular; Molecular Structure; Quinolones; Receptor, Cannabinoid, CB1; Receptor, Cannabinoid, CB2; Structure-Activity Relationship	2006
Biarylpyrazole inverse agonists at the cannabinoid CB1 receptor: importance of the C-3 carboxamide oxygen/lysine3.28(192) interaction. Journal of medicinal chemistry, 2006, Oct-05, Volume: 49, Issue:20 Topics: Amides; Amino Acid Sequence; Animals; Binding Sites; Binding, Competitive; Calcium; Cell Line; Humans; In Vitro Techniques; Ligands; Lysine; Models, Molecular; Molecular Sequence Data; Molecular Structure; Mutation; Neurons; Oxygen; Pyrazoles; Radioligand Assay; Rats; Receptor, Cannabinoid, CB1; Stereoisomerism; Superior Cervical Ganglion; Thermodynamics	2006
Arylsulfonamides as a new class of cannabinoid CB1 receptor ligands: identification of a lead and initial SAR studies. Bioorganic & medicinal chemistry letters, 2007, Jan-01, Volume: 17, Issue:1 Topics: Analgesics; Animals; Benzoates; Humans; Ligands; Male; Mice; Mice, Inbred Strains; Receptor, Cannabinoid, CB1; Structure-Activity Relationship; Sulfonamides	2007
Naphthalen-1-yl-(4-pentyloxynaphthalen-1-yl)methanone: a potent, orally bioavailable human CB1/CB2 dual agonist with antihyperalgesic properties and restricted central nervous system penetration. Journal of medicinal chemistry, 2007, Aug-09, Volume: 50, Issue:16 Topics: Administration, Oral; Analgesics; Animals; Biological Availability; Brain; Cricetinae; Cricetulus; Cyclic AMP; Humans; Hyperalgesia; In Vitro Techniques; Microsomes, Liver; Naphthalenes; Radioligand Assay; Rats; Rats, Wistar; Receptor, Cannabinoid, CB1; Receptor, Cannabinoid, CB2; Structure-Activity Relationship	2007
Pharmacomodulations around the 4-oxo-1,4-dihydroquinoline-3-carboxamides, a class of potent CB2-selective cannabinoid receptor ligands: consequences in receptor affinity and functionality. Journal of medicinal chemistry, 2007, Nov-01, Volume: 50, Issue:22 Topics: Amides; Animals; Binding, Competitive; CHO Cells; Cricetinae; Cricetulus; Drug Inverse Agonism; Humans; Ligands; Quinolines; Radioligand Assay; Receptor, Cannabinoid, CB2; Stereoisomerism; Structure-Activity Relationship	2007
Discovery and optimization of a novel series of N-arylamide oxadiazoles as potent, highly selective and orally bioavailable cannabinoid receptor 2 (CB2) agonists. Journal of medicinal chemistry, 2008, Aug-28, Volume: 51, Issue:16 Topics: Administration, Oral; Aminoquinolines; Animals; Biological Availability; CHO Cells; Cricetinae; Cricetulus; Drug Evaluation, Preclinical; Humans; Models, Molecular; Oxadiazoles; Rats; Receptor, Cannabinoid, CB2; Structure-Activity Relationship	2008
Synthesis and pharmacological evaluation of coumarin derivatives as cannabinoid receptor antagonists and inverse agonists. Bioorganic & medicinal chemistry, 2009, Apr-01, Volume: 17, Issue:7 Topics: Animals; Cell Line; Coumarins; Drug Inverse Agonism; Humans; Rats; Receptor, Cannabinoid, CB1; Receptor, Cannabinoid, CB2; Species Specificity; Structure-Activity Relationship	2009
Two distinct classes of novel pyrazolinecarboxamides as potent cannabinoid CB1 receptor agonists. Bioorganic & medicinal chemistry letters, 2010, Sep-01, Volume: 20, Issue:17 Topics: Pyrazoles; Receptor, Cannabinoid, CB1	2010
4-Oxo-1,4-dihydropyridines as selective CB2 cannabinoid receptor ligands: structural insights into the design of a novel inverse agonist series. Journal of medicinal chemistry, 2010, Nov-25, Volume: 53, Issue:22 Topics: Amino Acid Sequence; Animals; CHO Cells; Cricetinae; Cricetulus; Dihydropyridines; Drug Inverse Agonism; Humans; Ligands; Models, Molecular; Molecular Sequence Data; Radioligand Assay; Receptor, Cannabinoid, CB2; Sequence Alignment; Stereoisomerism; Structure-Activity Relationship	2010
Design, synthesis, and structure-activity relationship study of bicyclic piperazine analogs of indole-3-carboxamides as novel cannabinoid CB1 receptor agonists. Bioorganic & medicinal chemistry letters, 2010, Dec-15, Volume: 20, Issue:24 Topics: Amides; Animals; Azabicyclo Compounds; Bridged Bicyclo Compounds; Drug Design; Humans; Indoles; Mice; Microsomes, Liver; Piperazines; Receptor, Cannabinoid, CB1; Structure-Activity Relationship	2010
Three-dimensional quantitative structure-selectivity relationships analysis guided rational design of a highly selective ligand for the cannabinoid receptor 2. European journal of medicinal chemistry, 2011, Volume: 46, Issue:2 Topics: Computer Simulation; Drug Design; Humans; Ligands; Models, Molecular; Molecular Structure; Quantitative Structure-Activity Relationship; Quinolones; Receptor, Cannabinoid, CB1; Receptor, Cannabinoid, CB2; Recombinant Proteins; Stereoisomerism	2011
Discovery of potent and orally bioavailable heterocycle-based cannabinoid CB1 receptor agonists. Bioorganic & medicinal chemistry letters, 2011, Mar-15, Volume: 21, Issue:6 Topics: Administration, Oral; Animals; Biological Availability; Drug Discovery; Heterocyclic Compounds; Rats; Receptor, Cannabinoid, CB1	2011
Novel indole and azaindole (pyrrolopyridine) cannabinoid (CB) receptor agonists: design, synthesis, structure-activity relationships, physicochemical properties and biological activity. European journal of medicinal chemistry, 2011, Volume: 46, Issue:10 Topics: Animals; Brain; Cannabinoid Receptor Agonists; CHO Cells; Cricetinae; Humans; Indoles; Ligands; Male; Rats; Rats, Wistar; Receptor, Cannabinoid, CB2; Receptors, Cannabinoid; Structure-Activity Relationship	2011
Resorcinol-sn-glycerol derivatives: novel 2-arachidonoylglycerol mimetics endowed with high affinity and selectivity for cannabinoid type 1 receptor. Journal of medicinal chemistry, 2011, Dec-22, Volume: 54, Issue:24 Topics: Animals; Arachidonic Acids; Brain; CHO Cells; Cricetinae; Cricetulus; Cytochrome P-450 CYP3A; Endocannabinoids; Esterases; Esters; Ethers; Glycerides; HEK293 Cells; Humans; In Vitro Techniques; Mice; Molecular Mimicry; Monoglycerides; Phenols; Receptor, Cannabinoid, CB1; Receptor, Cannabinoid, CB2; Resorcinols; Stereoisomerism; Structure-Activity Relationship	2011
Low brain penetrant CB1 receptor agonists for the treatment of neuropathic pain. Bioorganic & medicinal chemistry letters, 2012, Apr-15, Volume: 22, Issue:8 Topics: Animals; Brain; Caco-2 Cells; Drug Design; Humans; Indoles; Mice; Neuralgia; Oxadiazoles; Rats; Receptor, Cannabinoid, CB1	2012
3-Carboxamido-5-aryl-isoxazoles as new CB2 agonists for the treatment of colitis. Bioorganic & medicinal chemistry, 2013, Sep-01, Volume: 21, Issue:17 Topics: Animals; Anti-Inflammatory Agents; Cell Proliferation; Colitis; Dextran Sulfate; HT29 Cells; Humans; Interleukin-1beta; Isoxazoles; Male; Mice; Mice, Inbred C57BL; Protein Binding; Receptor, Cannabinoid, CB1; Receptor, Cannabinoid, CB2; Structure-Activity Relationship; Tumor Necrosis Factor-alpha	2013
Mastering tricyclic ring systems for desirable functional cannabinoid activity. European journal of medicinal chemistry, 2013, Volume: 69 Topics: Animals; Carbazoles; Dose-Response Relationship, Drug; Humans; Models, Molecular; Molecular Structure; Neuralgia; Rats; Receptor, Cannabinoid, CB1; Receptor, Cannabinoid, CB2; Structure-Activity Relationship	2013
Development of fluorinated CB(2) receptor agonists for PET studies. Bioorganic & medicinal chemistry, 2013, Dec-01, Volume: 21, Issue:23 Topics: Animals; Carbazoles; CHO Cells; Cricetulus; Halogenation; Humans; Ligands; Molecular Docking Simulation; Positron-Emission Tomography; Receptor, Cannabinoid, CB2; Structure-Activity Relationship	2013
Structure-affinity relationships and pharmacological characterization of new alkyl-resorcinol cannabinoid receptor ligands: Identification of a dual cannabinoid receptor/TRPA1 channel agonist. Bioorganic & medicinal chemistry, 2014, Sep-01, Volume: 22, Issue:17 Topics: Analgesics; Animals; Calcium Channels; Cell Survival; Cells, Cultured; CHO Cells; Cricetulus; Dose-Response Relationship, Drug; Humans; Ligands; Male; Mice; Molecular Structure; Nerve Tissue Proteins; NIH 3T3 Cells; Nociception; Pain; Pain Measurement; Receptor, Cannabinoid, CB1; Receptor, Cannabinoid, CB2; Resorcinols; Structure-Activity Relationship; Transient Receptor Potential Channels; TRPA1 Cation Channel	2014
One-pot heterogeneous synthesis of Δ(3)-tetrahydrocannabinol analogues and xanthenes showing differential binding to CB(1) and CB(2) receptors. European journal of medicinal chemistry, 2014, Oct-06, Volume: 85 Topics: Chemistry Techniques, Synthetic; Dronabinol; Humans; Microwaves; Protein Binding; Receptor, Cannabinoid, CB1; Receptor, Cannabinoid, CB2; Substrate Specificity; Xanthenes	2014
Chromenopyrazole, a Versatile Cannabinoid Scaffold with in Vivo Activity in a Model of Multiple Sclerosis. Journal of medicinal chemistry, 2016, 07-28, Volume: 59, Issue:14 Topics: Dose-Response Relationship, Drug; HEK293 Cells; Humans; Models, Molecular; Molecular Structure; Multiple Sclerosis; Pyrazoles; Receptor, Cannabinoid, CB1; Receptor, Cannabinoid, CB2; Structure-Activity Relationship	2016
Alkyl indole-based cannabinoid type 2 receptor tools: Exploration of linker and fluorophore attachment. European journal of medicinal chemistry, 2018, Feb-10, Volume: 145 Topics: Dose-Response Relationship, Drug; Fluorescent Dyes; Humans; Indoles; Ligands; Models, Molecular; Molecular Structure; Receptor, Cannabinoid, CB2; Structure-Activity Relationship	2018
Polypharmacological profile of 1,2-dihydro-2-oxo-pyridine-3-carboxamides in the endocannabinoid system. European journal of medicinal chemistry, 2018, Jun-25, Volume: 154 Topics: Dose-Response Relationship, Drug; Endocannabinoids; Humans; Molecular Docking Simulation; Molecular Structure; Pyridines; Receptors, Cannabinoid; Structure-Activity Relationship; Tumor Cells, Cultured; U937 Cells	2018
Bioisosteric replacement of central 1,2,4-oxadiazole ring of high affinity CB MedChemComm, 2017, Aug-01, Volume: 8, Issue:8 Topics:	2017
Isolation of a High-Affinity Cannabinoid for the Human CB1 Receptor from a Medicinal Journal of natural products, 2020, 01-24, Volume: 83, Issue:1 Topics: Analgesics; Animals; Cannabidiol; Cannabinoids; Cannabis; Dronabinol; Humans; Medical Marijuana; Mice; Molecular Structure; Receptor, Cannabinoid, CB1; Receptor, Cannabinoid, CB2	2020
Synthetic bioactive olivetol-related amides: The influence of the phenolic group in cannabinoid receptor activity. Bioorganic & medicinal chemistry, 2020, 06-01, Volume: 28, Issue:11 Topics: Amides; Analgesics; Animals; Cell Line; Dose-Response Relationship, Drug; Humans; Male; Mice; Molecular Structure; Rats; Receptors, Cannabinoid; Resorcinols; Structure-Activity Relationship; TRPV Cation Channels	2020
Carbon-silicon switch led to the discovery of novel synthetic cannabinoids with therapeutic effects in a mouse model of multiple sclerosis. European journal of medicinal chemistry, 2021, Dec-15, Volume: 226 Topics: Animals; Cannabinoids; Carbon; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Discovery; Encephalomyelitis, Autoimmune, Experimental; Male; Mice; Mice, Inbred C57BL; Molecular Structure; Multiple Sclerosis; Receptor, Cannabinoid, CB1; Receptor, Cannabinoid, CB2; Silicon; Structure-Activity Relationship	2021